Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Nominee Leavitt Leaves Medicare Rx Implementation Team Intact

Executive Summary

President Bush's nomination of Michael Leavitt to head HHS will allow implementation of the Medicare prescription drug benefit to continue without distractions

You may also be interested in...



HHS Nominee Pledges To Protect FDA “Brand”; Commissioner Coming Soon

Upholding the trustworthiness of the FDA "brand" will be one of Michael Leavitt's priorities as HHS Secretary, the nominee said during his Jan. 18 confirmation hearing before the Senate Health Committee

HHS Nominee Pledges To Protect FDA “Brand”; Commissioner Coming Soon

Upholding the trustworthiness of the FDA "brand" will be one of Michael Leavitt's priorities as HHS Secretary, the nominee said during his Jan. 18 confirmation hearing before the Senate Health Committee

Canada-Only Import Plan “Feasible,” HHS Says: Savings Would Be “Modest”

The Bush Administration would accept a Canada-only importation program that focuses solely on high volume brands, HHS Secretary Thompson and Commerce Secretary Donald Evans indicated in a Dec. 21 letter to Congress

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045132

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel